PEBC Report - Programa de Epigenética y Biología del Cáncer

Welcome address by Manel Esteller,
PEBC Director
I
t was a great pleasure to announce the launching in 2008 of a new
research program supported by the Department de Salut de la
Generalitat de Catalunya within the IDIBELL devoted to biomedical
sciences, the "Cancer Epigenetics and Biology Program" (PEBC) that
I have the honour to direct.
Current research projects developed at the PEBC include, but are not
restricted to, cancer epigenetics, chromatin and stem cell biology,
aging, cell cycle and transformation, imprinting and the identification
of cancer genes. The PEBC is located in the outskirts of Barcelona
(Catalonia, Spain) within walking distance of metro station and ten
minutes driving from the airport. It is located in a biomedical and scientific
campus that includes two Hospitals (Hospital de Bellvitge and
Hospital Duran i Reynals), the School of Medicine of the University of
Barcelona, The Bellvitge Institute for Biomedical Research (IDIBELL)
and an area of biotech development (Biopol).
Barcelona has recently made an enormous effort in biomedical research and the PEBC is the last
new addition to this trend. The foundational goals of the PEBC are the development of high-quality
basic research with a potential application for the benefit of the cancer patient in a scientific environment
of international excellence. The current “Cancer Epigenetics and Biology Symposium”
brings together the world class experts in the different pathways leading to human tumors and all
of us will benefit from their superb and original investigations.
I look forward to hearing from you, I extend my invitation to visit our place and our beautiful city, I
wish you a pleasant exploration of the PEBC web site (http://www.pebc.cat/) and a wonderful
enjoyment of the scientific meeting.
My best wishes,
Manel Esteller
M.D., PhD. PEBC Director
5